Abstract
The pathophysiology of CINV is not entirely understood; however, it is thought to have many contributing pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358:2482-2494.
Wang SC, Borison HL. The vomiting center; a critical experimental analysis. Arch Neurol Psychiatry. 1950;63:928-941.
Andrews PL, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125:100-115.
Miller FR. On gastric sensation. J Physiol. 1910;41:409-415.
Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111(suppl 8A):106S-112S.
Gralla RJ. Current issues in the management of nausea and vomiting. Ann Oncol. 1993;4(suppl 3):3-7.
Rapport MM, Green AA, Page IH. Crystalline serotonin. Science. 1948;108:329-330.
Miller AD, Nonaka S, Jakus J. Brain areas essential or non-essential for emesis. Brain Res. 1994;647:255-264.
Moulignier A. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Rev Neurol (Paris). 1994;150:3-15.
Peroutka SJ, Snyder SH. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981;208:339-347.
Gralla RJ, Itri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981;305:905-909.
Leibundgut U, Lancranjan I. First results with ICS 205-930 (5-HT 3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet. 1987;1:1198.
Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med. 2001;249:27-40.
Kris MG, Radford JE, Pizzo BA, et al. Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin. J Natl Cancer Inst. 1997;89:817-818.
Carpenter DO, Briggs DB, Strominger N. Responses of neurons of canine area postrema to neurotransmitters and peptides. Cell Mol Neurobiol. 1983;3:113-126.
Herrstedt J, Dombernowsky P. Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol. 2007;101:143-150.
Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;19:379-390.
Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol. 2007;61:162-175.
Roila F, Donati D, Tamberi S, Margutti G. Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer. 2002;10:88-95.
Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2005;13:117-121.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer Healthcare
About this chapter
Cite this chapter
Aapro, M., Jordan, K., Feyer, P. (2013). Pathophysiology and Classification of Chemotherapy-Induced Nausea and Vomiting. In: Prevention of Nausea and Vomiting in Cancer Patients. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-58-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-907673-58-0_2
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-87-6
Online ISBN: 978-1-907673-58-0
eBook Packages: MedicineMedicine (R0)